Endometrial ablation devices are used to remove the endometrium, which is the lining of the uterus. This procedure used for the treatment of menorrhagia when it is not controlled with the help of medications. Increase in prevalence of menstrual disorders and rise in awareness about endometrial ablation devices majorly drive the growth of the endometrial ablation devices market.

In addition, endometrial ablation offers some advantages, such as speed of treatment, efficiency, and minimally invasive procedure. These fuels market growth globally.

According to a new report published by Allied Market Research, titled, "Endometrial Ablation Devices Market, by Technology and End User: Global Opportunity Analysis and Industry Forecast, 2018 to 2024," the market was valued at $882 million in 2017, and is expected to reach $1,299 million by 2024, growing at a CAGR of 5.6% from 2018 to 2024.

Download sample copy @ https://www.alliedmarketresearch.com/request-sample/4632

Based on technology type, the market is segmented into radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others. At present, the radiofrequency ablation segment generates a major share of revenue due to the speed of procedure and efficiency. On the other side, thermal balloon technology segment is anticipated to show the fastest growth during the forecast period primarily owing to its safety and procedure convenience.

Based on the end user, the clinic segment occupied the largest share in 2017 and is anticipated to continue its dominance during the forecast period, due to the availability of portable and easy to use endometrial ablation devices. However, the ambulatory surgery center segment is anticipated to exhibit the fastest market growth during the forecast period owing to a convenient environment as well as a rise in the number of ambulatory surgery centers.

Key Findings of the Endometrial Ablation Devices Market:

•Based on technology, the thermal balloon segment is expected to show the fastest market growth, at a CAGR of 6.8% from 2018 to 2024.

•Based on technology, the radiofrequency ablation segment held more than one-third share in 2017 and is expected to remain dominant throughout the forecast period.

•Based on the end user, the ambulatory surgery segment exhibited the fastest growth at a CAGR of 6.2% from 2018 to 2024.

•Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.8% during the forecast period.

Major Players:

• AEGEA Medical Inc.
• Boston Scientific Corporation
• CooperSurgical Inc.
• Hologic Inc.
• Idoman Teoranta
• Minerva Surgical Inc.
• Olympus Corporation
• Omnitech Systems Inc.
• Smith & Nephew plc.
• Veldana Medical SA.

Send enquiry us @ https://www.alliedmarketresearch.com/purchase-enquiry/4632